Preferences help
enabled [disable] Abstract
Number of results
2008 | 3 | 2 | 199-202
Article title

IL-2, IL-6 and IL-8 levels remain unaltered in the course of immunosuppressive therapy after renal transplantation

Title variants
Languages of publication
Cytokines regulate the immune reactions elicited by renal transplantation (RT). This study was designed to investigate the blood serum levels of IL-2, IL-6, IL-8 in 25 RT patients (10 female and 15 male, mean 5.4±2.7 yrs after RT) three times over a six-month period during standard immunosuppressive therapy with cyclosporine A, azathioprine and prednisolone. The levels of IL-2, IL-6 and IL-8 were tested with ELISA Quantikine Human Interleukin Immunoassay (R&D Systems, detection level 7,0.7 and 10 pg/cm3, respectively). There was no significant alternation of blood serum levels of IL-2, IL-6 and IL-8 in the study patients.
Physical description
1 - 6 - 2008
9 - 4 - 2008
  • 2nd Department of Family Medicine, Medical University of Lodz, 90-549, Lodz, Poland
  • 2nd Department of Family Medicine, Medical University of Lodz, 90-549, Lodz, Poland
  • 2nd Department of Family Medicine, Medical University of Lodz, 90-549, Lodz, Poland
  • 2nd Department of Family Medicine, Medical University of Lodz, 90-549, Lodz, Poland
  • Department of Experimental and Clinical Physiology, Medical University of Lodz, 92-215, Lodz, Poland
  • Department of Anaesthesiology and Intensive Care Unit, University Hospital No. 5 in Lodz, Medical University of Lodz, 90-647, Lodz, Poland
  • [1] Whicher J.T., Evans S.W., Cytokines in disease, Clin. Chem., 1990, 36, 1269–1281
  • [2] Rysz J., Banach M., Ciałkowska-Rysz A., Stolarek R., Drozdz J., Okoński P., Blood serum levels of IL-2, IL-6, IL-8, TNF-a and IL-1b in patients on maintenance hemodialysis, Cell. Mol. Immunol., 2006, 3, 151–154
  • [3] Descamps-Latscha B., Herbelin A., Nguyen A.T., Roux-Lombard P., Zingraff J., Moynot A., et al., Balance between IL-1b, TNF-a, and their specific inhibitors in chronic renal failure and maintenance dialysis, J. Immunol., 1995, 154, 882–892
  • [4] Bock G.H., Neu L., Long C., Patterson L.T., Korb S., Gelpi J., et al., Assessment of serum and urine soluble interleukin-2 receptor concentration during renal transplant rejection, Am. J. Kidney Dis., 1994, 23, 421–426 [Crossref]
  • [5] Dobbelstein H., Immune system in uremia, Nephron, 1976, 17, 409–414 [Crossref]
  • [6] Kang X., Hirano T., Oka K., Tamak T., Samurai E., Kaji N., et al., Recovery of decreased ability of peripheral-blood mononuclear cells from chronic renal failure to produce interleukin-1 after renal transplantation. Nephron, 1991, 58, 450–455[Crossref]
  • [7] Rysz J., Stolarek R.A., Majewska E., Banach M., Cialkowska-Rysz A., Baj Z., The increased levels of soluble TNFa receptors and cellular adhesion molecules in patients undergoing bioincompatible hemodialysis, Am. J. Nephrol., 2006, 26, 437–444[Crossref]
  • [8] Allegre M.L., Costimulatory molecules as targets for the induction of transplantation tolerance, Nephrol. Dial. Transplant., 1999, 14, 322–332[Crossref]
  • [9] Jakóbisiak M.,Immunologia. Wydawnictwo Naukowe PWN, Warszawa, Poland, 141–145, 478–524, 1993
  • [10] Schwarz C., Oberbauer R., The influence of organ donor factors on early allograft function, Curr. Opin. Urol., 2003, 13, 99–104[Crossref]
  • [11] Hermelin A., Urena P., Nguyen A.T., Zingraff J., Descamps-Latscha B., Elevated circulating levels of interleukin-6 in patients with chronic failure, Kidney Int., 1991, 39, 954–960[Crossref]
  • [12] Kutuckuler N., Clark K., Rigg K.M., The value of posttransplant monitoring of IL-2, IL-3, IL-4, IL-6, IL-8 and soluble CD23 in the plasma of renal allograft recipients, Transplantation, 1995, 59, 333–337
  • [13] Budde K., Waiser J., Ceska J., Katalinic A., Kürzdörfer M., Neumayer H.H., Interleukin-8 expression in patients after renal transplantation, Am. J. Kidney Dis., 1997, 29, 871–875[Crossref]
  • [14] Boratynska M., Urine and serum levels of interleukin-8 in patients after renal transplantation, Przegl. Lek. 1998, 55, 576–580
  • [15] Waiser J., Budde K., Katalinic A., Kuerzdörfer M., Riess R., Neumayer H.H., Interleukin-6 expression after renal transplantation. Nephrol. Dial. Transplant., 1997, 12, 753–759[Crossref]
  • [16] Noronha I., Niemir Z., Stein H., Waldherr R., Cytokines and growth factors in renal disease, Nephrol. Dial. Transplant., 1995, 10, 775–786
  • [17] Bachórzewska-Gajewska H., Małyszko J., Sitniewska E., Małyszko J., Dobrzycki S., Prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary interventions in everyday clinical practice, Arch. Med. Sci., 2006, 2, 256–261
  • [18] Rysz J., Stolarek R., Banach M., Pasnik J., Okoński P., Baj Z., et al. TNF-alfa priming effect on polymorphonuclear leukocytes reactive species generation and adhesion molecule expression in hemodialyzed patients, Arch. Immunol. Ther. Exp., 2006, 54, 209–215[Crossref]
  • [19] Rysz J., Kocur E., Błaszczak R., Stolarek R., Integrin CD11a/CD18, CD11b/CD18 and CD69 expression in patients after renal transplantation, Cent. Eur. J. Med., 2007, 2, 154–158[WoS][Crossref]
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.